DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo


16.05 1.68 (11.69%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

INSM $16.05 11.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $14.56
Previous Close $14.37
Daily Range $14.53 - $16.15
52-Week Range $11.25 - $22.29
Market Cap $797.1M
P/E Ratio -7.52
Dividend (Yield) $0.00 (0.0%)
Volume 890,722
Average Daily Volume 528,827
Current FY EPS -$2.07





INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Use Options For a Chance To Buy INSM at a 52% Discount

Update: Insmed Q3 2014 Earnings

Insmed's (INSM) CEO Bill Lewis on Q3 2014 Results - Earnings Call Transcript

Insmed (INSM) Q3 2014 Results - Earnings Call Webcast

5 Red-Hot Biotech Stocks to Buy

Insmed Incorporated (INSM) in Focus: Stock Up 10.9% - Tale of the Tape

Markets Rise; Macy's Lowers Comparable Sales Outlook

Markets Rise; Macy's Lowers Comparable Sales Outlook

Benzinga's Volume Movers

Sector Update: Health Care

See More INSM News...

INSM's Top Competitors

INSM $16.05 (11.69%)
Current stock: INSM
AMGN $168.48 (3.06%)
Current stock: AMGN
GILD $105.54 (3.07%)
Current stock: GILD
BIIB $353.70 (6.25%)
Current stock: BIIB